Virginia Beach, VA
Thursday, June 24, 2010
Ruth's Chris Steak House
205 Central Park Avenue
Virginia Beach, VA 23462

Fernando Pagan, MD (Co-Chair)
Assistant Professor
Movement Disorder Specialist
Department of Neurology
Georgetown University School of Medicine
Washington, DC

Carlo Tornatore, MD (Co-Chair)
Associate Professor
Department of Neurology
Georgetown University School of Medicine
Washington, DC

Upon the conclusion of Evolution of Parkinson Disease and Treatments, the participant should be better able to:

• EXPLAIN the process of neurodegeneration in PD.
• DESCRIBE why neuroprotection is important in reducing the biochemical insults responsible for cellular damage in PD.
• CONTRAST disease progression from suboptimal treatment of PD by identifying patients in need of early treatment.
• IDENTIFY appropriate clinical use of current and future therapies in patients with early, moderate, and advanced PD.

Upon the conclusion of Lessons We’ve Learned from Clinical Trials in MS, the participant should be able to:

• REVIEW the outcomes of the clinical trials validating the use of disease modifying drugs (DMDs) for clinically isolated syndrome.
• EXPLAIN why initiating treatment early on in the course of the disease may decrease disability progression and increase neuroprotection.
• DESCRIBE how current treatments can be utilized to optimize patient care and decrease disease progression.
• DIFFERENTIATE between the efficacy of novel immunotherapies at reducing disability and relapse rate to currently available DMDs.

GOAL – This educational activity has been designed to enhance neurologists’, MS specialists’, and PD specialists’ knowledge of diagnosis strategies for both MS and PD, as well as provide an update on the newest trends in treating patients with MS and PD.

TARGET AUDIENCE – The educational design of this activity addresses the needs of neurologists, MS specialists, and PD specialists involved in the treatment of patients with MS. No prerequisites required.

ACCREDITATION STATEMENT –This activity has been planned and implemented in accordance with the Essential Areas and
policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Global
Education Group and ASiM. Global Education Group is accredited by the ACCME to provide continuing medical education for
physicians.

CREDIT DESIGNATION STATEMENT – Global Education Group designates this educational activity for a maximum of 2.0 AMA
PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

POLICY ON FACULTY AND PROVIDER DISCLOSURE – Global Education Group requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

AMERICANS WITH DISABILITIES ACT (ADA) – Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact ASiM prior to the live event at 908-253-9001.

FEE INFORMATION – There is no fee for this educational activity.